BACKGROUND: Mathematical models have proven helpful in analyzing the virological response to antiviral therapy in hepatitis C virus (HCV) infected subjects. OBJECTIVE: To summarize the uses and limitations of different models for analyzing HCV kinetic data under pegylated IFN therapy. METHODS: We formulate mathematical models and fit them by nonlinear least square regression to patient data to estimate model parameters. We compare the goodness of fit and parameter values estimated by different models statistically. RESULTS/ CONCLUSION: The best model for parameter estimation depends on the availability and the quality of data as well as the therapy used. We also discuss the mathematical models that will be needed to analyze HCV kinetic data from clinical trials with new antiviral drugs.
BACKGROUND: Mathematical models have proven helpful in analyzing the virological response to antiviral therapy in hepatitis C virus (HCV) infected subjects. OBJECTIVE: To summarize the uses and limitations of different models for analyzing HCV kinetic data under pegylated IFN therapy. METHODS: We formulate mathematical models and fit them by nonlinear least square regression to patient data to estimate model parameters. We compare the goodness of fit and parameter values estimated by different models statistically. RESULTS/ CONCLUSION: The best model for parameter estimation depends on the availability and the quality of data as well as the therapy used. We also discuss the mathematical models that will be needed to analyze HCV kinetic data from clinical trials with new antiviral drugs.
Authors: Stefan Zeuzem; Eric M Yoshida; Yves Benhamou; Stephen Pianko; Vincent G Bain; Daniel Shouval; Robert Flisiak; Vratislav Rehak; Mircea Grigorescu; Kelly Kaita; Patrick W Cronin; Erik Pulkstenis; G Mani Subramanian; John G McHutchison Journal: Hepatology Date: 2008-08 Impact factor: 17.425
Authors: Peter Ferenci; Hermann Laferl; Thomas-Matthias Scherzer; Michael Gschwantler; Andreas Maieron; Harald Brunner; Rudolf Stauber; Martin Bischof; Bernhard Bauer; Christian Datz; Karin Löschenberger; Elisabeth Formann; Katharina Staufer; Petra Steindl-Munda Journal: Gastroenterology Date: 2008-05-27 Impact factor: 22.682
Authors: Alison A Murphy; Eva Herrmann; Anu O Osinusi; Lynn Wu; William Sachau; Richard A Lempicki; Jun Yang; Tje L Chung; Tei L Chung; Brad J Wood; Bart L Haagmans; Shyam Kottilil; Michael A Polis Journal: AIDS Date: 2011-06-01 Impact factor: 4.177
Authors: Anuoluwapo Osinusi; Eric G Meissner; Yu-Jin Lee; Dimitra Bon; Laura Heytens; Amy Nelson; Michael Sneller; Anita Kohli; Lisa Barrett; Michael Proschan; Eva Herrmann; Bhavana Shivakumar; Wenjuan Gu; Richard Kwan; Geb Teferi; Rohit Talwani; Rachel Silk; Colleen Kotb; Susan Wroblewski; Dawn Fishbein; Robin Dewar; Helene Highbarger; Xiao Zhang; David Kleiner; Brad J Wood; Jose Chavez; William T Symonds; Mani Subramanian; John McHutchison; Michael A Polis; Anthony S Fauci; Henry Masur; Shyamasundaran Kottilil Journal: JAMA Date: 2013-08-28 Impact factor: 56.272
Authors: Susanna Naggie; Anu Osinusi; Antonios Katsounas; Richard Lempicki; Eva Herrmann; Alexander J Thompson; Paul J Clark; Keyur Patel; Andrew J Muir; John G McHutchison; Joerg F Schlaak; Martin Trippler; Bhavana Shivakumar; Henry Masur; Michael A Polis; Shyam Kottilil Journal: Hepatology Date: 2012-07-02 Impact factor: 17.425
Authors: Laetitia Canini; Jeremie Guedj; Anushree Chatterjee; Annabelle Lemenuel-Diot; Patrick F Smith; Alan S Perelson Journal: Antivir Ther Date: 2015-11-10